{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Showing 1 - 2 of 2 results
Status:
Other
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
First approved in 2015
Source:
BIOVITA by ILDONG PHARMACEUTICAL CO., LTD.
Source URL:
Class:
STRUCTURALLY DIVERSE